Home IT and Telecom Vidly TV Team Strongly Condemns India’s Move to Prohibit Pakistan OTT Platform

Vidly TV Team Strongly Condemns India’s Move to Prohibit Pakistan OTT Platform

11
0

Vidly TV, a Pakistani OTT platform, has replied to a restriction issued by the Indian Ministry of Information and Broadcasting (IMoIB) after the publication of Sevak: The Confessions.

The IMoIB banned the OTT platform in India after the publication of the recently published web series, Sevak: The Confessions, claiming that the programme includes material that is damaging to India’s national security, sovereignty, and integrity.

While speaking to the media, the Vidly TV Team denounced India’s action, stating that we (Pakistan) never restrict their programming and treat it as entertainment.

“This online series had barely launched three episodes and India banned it in its territory,” claimed Sevak’s Senior producer.

He went on to say that the web series is based on facts taken from Indian authors’ works.

The screenwriter of the series, Saji Gul, stated that the programme emphasises the genuine experiences of the Indian minority, and therefore the IMoIB has banned it out of terror.

“It shows the true instances that occurred to minorities,” he remarked. You cannot, in my opinion, outlaw the internet. looming above the looming looming looming looming looming glening glen

The trailer for VidlyTV’s first original production, Sevak: The Confessions, has received over two million views on the video streaming platform YouTube.

The action-thriller Sevak: The Confessions is based on genuine occurrences of minority prejudice in India between 1984 and 2022.

The series consists of eight episodes that depict the horrors of hate crimes, massacres, and genocide against India’s minorities, mainly Muslims and Sikhs.

Previous articleTurkcell and VEON announce strategic partnership to advance BiP in Pakistan
Next articlePRG Pakistan Celebrates Another Year of Success and Recognizes Employees’ Achievements

LEAVE A REPLY

Please enter your comment!
Please enter your name here